Your browser doesn't support javascript.
loading
From Promise to Practice: Recent Growth in 30 Years of Tissue Engineering Commercialization.
Felix, Ryan B; Shabazz, Amal; Holeman, William Pieper; Han, Sarang; Wyble, Matthew; Uzoukwu, Marylyn; Gomes, Lauren Audrey; Nho, Laena; Litman, Mark Zachary; Hu, Peter; Fisher, John P.
Afiliação
  • Felix RB; Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
  • Shabazz A; Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland, USA.
  • Holeman WP; Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Han S; Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
  • Wyble M; Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland, USA.
  • Uzoukwu M; Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
  • Gomes LA; Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland, USA.
  • Nho L; Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
  • Litman MZ; Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland, USA.
  • Hu P; Fischell Department of Bioengineering, University of Maryland, College Park, Maryland, USA.
  • Fisher JP; Center for Engineering Complex Tissues, University of Maryland, College Park, Maryland, USA.
Tissue Eng Part A ; 2024 Jul 01.
Article em En | MEDLINE | ID: mdl-38818800
ABSTRACT
This perspective, marking the 30th anniversary of the Tissue Engineering journal, discusses the exciting trends in the global commercialization of tissue engineering technology. Within a historical context, we present an evolution of challenges and a discussion of the last 5 years of global commercial successes and emerging market trends, highlighting the continued expansion of the field in the northeastern United States. This leads to an overview of the last 5 years' progress in clinical trials for tissue-engineered therapeutics, including an analysis of trends in success and failure. Finally, we provide a broad overview of preclinical research and a perspective on where the state-of-the-art lies on the horizon.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Tissue Eng Part A Assunto da revista: BIOTECNOLOGIA / HISTOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Tissue Eng Part A Assunto da revista: BIOTECNOLOGIA / HISTOLOGIA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos